Stockreport

ReShape Lifesciences' (RSLS) CEO Dan Gladney on Q4 2017 Results - Earnings Call Transcript [Seeking Alpha]

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com
PDF ReShape Lifesciences Inc. (NASDAQ: RSLS ) Q4 2017 Earnings Conference Call April 2, 2018 4:30 PM ET Executives Dan Gladney - Chairman & CEO Scott Youngstro [Read more]